bexarotene has been researched along with Juvenile Sulfatidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrens-Nicklas, RC; Ballabio, A; Baud, M; Berulava, T; Brunetti-Pierri, N; Dierks, T; Fischer, A; French, DL; Gagne, A; Gärtner, J; Gelb, MH; Herbst, ZM; Kettwig, M; Maguire, JA; Monfregola, J; Pena, T; Radhakrishnan, K; Schlotawa, L; Schröder, S; Tyka, K; Waxman, EA | 1 |
1 other study(ies) available for bexarotene and Juvenile Sulfatidosis
| Article | Year |
|---|---|
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.
Topics: Bexarotene; Drug Evaluation, Preclinical; Humans; Multiple Sulfatase Deficiency Disease; Oxidoreductases Acting on Sulfur Group Donors; Sulfatases | 2023 |